Chicago teen who called for father’s release from ICE detention dies of rare cancerChicago teen who called for father’s release from ICE detention dies of rare cancer
A Chicago teenager whose father was detained by U.S.
US teen who pushed for her father’s release from ICE custody dies of cancerUS teen who pushed for her father’s release from ICE custody dies of cancer
Ofelia Torres, 16, spotlighted her dad Ruben’s illegal detention last fall during Trump’s crackdown in ChicagoA Chicago teenager, whose father was detained by immigration authorities while she navigated cancer, died on Friday, a family spokesperson said.Ofelia Torres, a 16-year-old in Chicago, had been undergoing treatment for an aggressive and rare form of cancer since late 2024. As she and her family struggled with the medical procedures, her father, Ruben Torres Maldonado, was detained by immigration authorities while at a Home Depot in October, leading to a contentious and public case that highlighted the human effects of the Trump administration’s aggressive immigration crackdown. Continue reading…
Will Ozempic-style patches help you lose weight? Two experts explainWill Ozempic-style patches help you lose weight? Two experts explain
Could a simple patch, inspired by the weight-loss drug Ozempic, really help you shed excess kilos without the pain and effort of an injection? Could a simple patch, inspired by the weight-loss drug Ozempic, really help you shed excess kilos without the pain and effort of an injection?
Obesity rates are rising, despite GLP-1s. What does it mean?Obesity rates are rising, despite GLP-1s. What does it mean?
By 2030, nearly half of all American adults will have obesity, according to research published in the New England Journal of Medicine. In every single state, researchers expect at least 35% of adults to have a body mass index of 30 or higher, the threshold that defines obesity. That prediction may come as a shock, Read More
Combining GLP-1 drugs with hormones may lower uterine cancer riskCombining GLP-1 drugs with hormones may lower uterine cancer risk
Adding GLP-1 medications like Ozempic to progestin therapy could cut the risk of developing endometrial cancer. A retrospective study published in the journal JAMA Network Open found that women using this combination had a much lower risk of developing the disease than those on progestins alone. Adding GLP-1 medications like Ozempic to progestin therapy could Read More
FDA Leader Accused of Sexual Harassment; RFK Jr.’s Toilet Comment; GLP-1s and ScurvyFDA Leader Accused of Sexual Harassment; RFK Jr.’s Toilet Comment; GLP-1s and Scurvy
(MedPage Today) — Note that some links may require registration or subscription. FDA vaccine chief Vinay Prasad, MD, MPH, who made the controversial decision to refuse to review Moderna’s mRNA flu vaccine, has been accused of sexual harassment… (MedPage Today) — Note that some links may require registration or subscription. FDA vaccine chief Vinay Read More
STAT+: Trump administration is urged to use a federal law to authorize generic versions of GLP-1 drugsSTAT+: Trump administration is urged to use a federal law to authorize generic versions of GLP-1 drugs
Public Citizen petitioned the Trump administration to use a federal law to authorize generic competitors for GLP-1 drugs for treating obesity and diabetes, arguing that prices are “unjustifiably high” for too many Americans. In arguing its case, the consumer advocacy group maintained that federal and state spending on the drugs — which are sold by Read More
Potentially Blinding Eye Condition Tied to Ozempic AgainPotentially Blinding Eye Condition Tied to Ozempic Again
(MedPage Today) — Risk for a rare, potentially blinding eye condition was low, but it was significantly higher in diabetes patients who started semaglutide (Ozempic) versus SGLT2 inhibitors, an observational study of U.S. veterans showed. Among… (MedPage Today) — Risk for a rare, potentially blinding eye condition was low, but it was significantly higher Read More
Genetic risk may rival obesity as a key driver of endometrial cancerGenetic risk may rival obesity as a key driver of endometrial cancer
A major new study has found genetics play a powerful and independent role in endometrial cancer risk—challenging the long-held belief that obesity is the primary driver. The findings could lead to better screening of the women most at risk of developing the disease.
Using GLP-1s to maintain a normal weight? There are benefits and risksUsing GLP-1s to maintain a normal weight? There are benefits and risks
Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric surgery to keep pounds from creeping back. Others may just want to lose a few pounds. (Image credit: Christie Woodard) Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are Read More